These results support a possible clinical continuum between TSC-associated neuropsychiatric disorders and neurodegenerative illness and highlight mTOR as a convergence point/link between neurodevelopmental and neurodegenerative processes, with a potential role of cytoskeleton dysfunction. This evidence concerns the gene MTOR and tuberous sclerosis.